PT98955A - Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao - Google Patents

Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao

Info

Publication number
PT98955A
PT98955A PT98955A PT9895591A PT98955A PT 98955 A PT98955 A PT 98955A PT 98955 A PT98955 A PT 98955A PT 9895591 A PT9895591 A PT 9895591A PT 98955 A PT98955 A PT 98955A
Authority
PT
Portugal
Prior art keywords
compositions containing
basic compound
insensibility
soluable
increasing
Prior art date
Application number
PT98955A
Other languages
English (en)
Other versions
PT98955B (pt
Inventor
Pieter De Haan
Cornelus Josephus Maria Va Ven
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT98955A publication Critical patent/PT98955A/pt
Publication of PT98955B publication Critical patent/PT98955B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)
PT98955A 1990-09-13 1991-09-12 Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao PT98955B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58185990A 1990-09-13 1990-09-13

Publications (2)

Publication Number Publication Date
PT98955A true PT98955A (pt) 1992-08-31
PT98955B PT98955B (pt) 1999-02-26

Family

ID=24326864

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98955A PT98955B (pt) 1990-09-13 1991-09-12 Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao

Country Status (14)

Country Link
EP (1) EP0475482B1 (pt)
JP (1) JP3153577B2 (pt)
KR (1) KR100196209B1 (pt)
AT (1) ATE112491T1 (pt)
AU (1) AU643920B2 (pt)
CA (1) CA2049811C (pt)
DE (1) DE69104453T2 (pt)
DK (1) DK0475482T3 (pt)
ES (1) ES2064887T3 (pt)
FI (1) FI104361B (pt)
IE (1) IE65274B1 (pt)
NZ (1) NZ239753A (pt)
PT (1) PT98955B (pt)
ZA (1) ZA916661B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2194867T3 (es) * 1993-03-26 2003-12-01 Franciscus Wilhelmus He Merkus Composiciones farmaceuticas para la administracion intranasal de apomorfina.
AU750361B2 (en) * 1997-03-26 2002-07-18 Franciscus W.H.M. Merkus Nasal melatonin composition
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US6691057B2 (en) 2001-02-26 2004-02-10 L.U.M. Gesellschaft Fur Labor- Umweltdiagnostic & Medizintechnik Mbh Method and device for accelerated stability analysis
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
CN102838599A (zh) 2006-05-04 2012-12-26 贝林格尔.英格海姆国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR102668834B1 (ko) 2009-11-27 2024-05-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 dpp-iv 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
ES2935300T3 (es) 2010-05-05 2023-03-03 Boehringer Ingelheim Int Combiterapia
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EA030121B1 (ru) 2011-07-15 2018-06-29 Бёрингер Ингельхайм Интернациональ Гмбх Замещенные хиназолины, их получение и их применение в фармацевтических композициях
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
RU2609198C1 (ru) * 2016-01-25 2017-01-30 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения
EP4233840A3 (en) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
KR102416406B1 (ko) * 2019-09-24 2022-07-04 주식회사 종근당 티카그렐러의 산 부가염을 포함하는 안정화된 약학 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554736A (en) 1951-05-29 Tertiary aminoalkyl-iminodibenzyls
US2018410A (en) 1933-12-11 1935-10-22 Victor Chemical Works Dentifrice preparation
US2287699A (en) 1940-02-15 1942-06-23 Monsanto Chemicals Stabilized dicalcium phosphate
US3012852A (en) 1956-06-06 1961-12-12 Monsanto Chemicals Stabilized calcium phosphates and process therefor
DE1277222B (de) 1965-12-22 1968-09-12 Knapsack Ag Verfahren zur Stabilisierung von Dicalciumphosphatdihydrat
NL129434C (pt) 1966-03-12
US4128641A (en) 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
DE2648061C2 (de) 1976-10-23 1982-11-04 Hoechst Ag, 6000 Frankfurt Verfahren zum Stabilisieren von Di-calciumhydrogenphosphatdihydrat
DE2741513A1 (de) 1977-09-15 1979-03-22 Benckiser Gmbh Joh A Verfahren zum stabilisieren von calciumhydrogenphosphat-dihydrat gegen hydrolyse
CA1183328A (en) 1980-12-12 1985-03-05 Thomas W. Gerard Compacting calcium phosphate
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US5004651A (en) 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions

Also Published As

Publication number Publication date
NZ239753A (en) 1992-10-28
CA2049811A1 (en) 1992-03-14
ES2064887T3 (es) 1995-02-01
AU8341691A (en) 1992-03-19
EP0475482A1 (en) 1992-03-18
FI914147A0 (fi) 1991-09-03
DE69104453T2 (de) 1995-03-16
KR920005978A (ko) 1992-04-27
FI914147A (fi) 1992-03-14
IE65274B1 (en) 1995-10-18
JPH0578236A (ja) 1993-03-30
ATE112491T1 (de) 1994-10-15
ZA916661B (en) 1992-06-24
IE913054A1 (en) 1992-02-25
DE69104453D1 (de) 1994-11-10
EP0475482B1 (en) 1994-10-05
PT98955B (pt) 1999-02-26
CA2049811C (en) 2002-11-05
FI104361B (fi) 2000-01-14
DK0475482T3 (da) 1995-04-03
AU643920B2 (en) 1993-11-25
KR100196209B1 (ko) 1999-06-15
JP3153577B2 (ja) 2001-04-09

Similar Documents

Publication Publication Date Title
PT98955A (pt) Processo de preparacao de composicoes quimicas secas estabilizadas contendo um sal de adicao de acido soluvel em agua de um composto basico pouco soluvel, e de aumento da insensibilidade de um procedimento de granulacao
ES8800041A1 (es) Un procedimiento para la produccion de una composicion farmaceutica de liberacion controlada de unidades individuales
US4273684A (en) Transparent detergent bar
ATE77547T1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
MX9706062A (es) FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA.
US4906647A (en) Stabilized pharmaceutical compositions
PT76219A (en) Process for the preparation of a fabric softening composition including an aqueous base a cationic lanoline softener and a viscosity control agent
SE7706126L (sv) Radioaktivt preparat
BR9609964A (pt) Formulação sólida estável de sal de enalaprila e processo para preparação da mesma
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK433681A (da) Fremgangsmaade til fremstilling af et antimikrobielt praeparat
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
MY101266A (en) Pharmaceutical formulations
DE68903017D1 (de) Aktives derivat von zirkonium und seine herstellung.
ES8800924A1 (es) Procedimiento para la obtencion de benzotiopiranonas
JPS565412A (en) Pharmaceutical composition
SE8804696L (sv) Dioxazocin- derivat, deras framstaellning och beredningar innehaallande desamma
HUT53096A (en) Process for producing thienylacetic acid derivatives and pharmaceutical compositions comprising same
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
FI900469A0 (fi) Aktivaemnen avgivande system med kontrollerad erosion och foerfarande foer dess framstaellning.
JPS54154729A (en) Aminobenzoic acid derivative and drug preparation containing the same
JPH01254626A (ja) ピコスルフアートナトリウム固型製剤
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
JPS54148753A (en) Antibiotic of aminoglycoside and its preparation

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920511

FG3A Patent granted, date of granting

Effective date: 19981109

PC4A Transfer of assignment

Owner name: N.V. ORGANON, NL

Effective date: 20061124

PD4A Change of proprietorship

Owner name: AKZO NOBEL N.V., NL

Effective date: 20061124

PC4A Transfer of assignment

Owner name: MSD OSS B.V., NL

Effective date: 20111209

PC4A Transfer of assignment

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V., NL

Effective date: 20130517

PC4A Transfer of assignment

Owner name: MERCK SHARP & DOHME B.V., NL

Effective date: 20130604

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20131111